BioSpace News Archive

Narcan Creator Takes on Synthetic Opioid Overdoses with Experimental Narcan Nasal Spray

The medication (Narcan nasal spray), should it be approved for use, will be squirted into the nasal passages, ensuring absorption into the body and reversing the overdose effects.

July 14, 2021
·
3 min read
·
Alex Keown
Policy

Bid to Wrest Phoenixus Away from Jailed ‘Pharma Bro’ Fails

Kevin Mulleady and Jason Aryeh attempted to back a slate of candidates for the Phoenixus Board of Directors but failed as shareholders overwhelmingly supported the current board.

July 14, 2021
·
2 min read
·
Alex Keown
Business

To Achieve What’s Possible, New Freenome CEO Mike Nolan ‘Makes His Own Weather’

The new CEO of Freenome has a talent for “making his own weather.” That’s a phrase he heard often growing up in Rapid City, South Dakota and, when applied to his life and career, comes down to assessing himself accurately and looking for opportunities to contribute.

July 14, 2021
·
5 min read
·
Gail Dutton
Global Roundup: Amniotics Snags $6.95 Million to Advance PulmoStem

Biopharma and life sciences companies from across the globe provide updates on their business practices and pipelines.

July 14, 2021
·
5 min read
·
Alex Keown
Policy

Pharma Faces a Turn in the Tides as Biden Demands Health Care Reforms

Biden calls out the Health and Human Services department to submit a plan in the next 45 days to combat excessive drug prices and enhance domestic pharmaceutical supply chains.

July 14, 2021
·
2 min read
·
Kate Goodwin
Drug Development

BioSpace’s Latest Clinical Report Highlights Successes and Failures in 2Q2021

In its 2Q2021 Clinical Report, BioSpace highlights drugs that were greenlit for clinical studies, faced clinical and regulatory hurdles and some who saw regulatory wins.

July 14, 2021
·
5 min read
·
Alex Keown
Deals

Lilly Spends $1 Billion-Plus on Insulin Innovator Protomer

No specific financial details were disclosed other than to say the $1 billion figure was linked to various development and commercial milestones.

July 14, 2021
·
3 min read
·
Mark Terry
Business

Moderna Aiming mRNA Technology at Viral Threats Beyond COVID-19

Moderna CEO Stéphane Bancel believes the promise of mRNA vaccines is so great they will become a disruptive force in preventing viral infections.

July 14, 2021
·
3 min read
·
Alex Keown
Business

Kriya Raises $100 M Series B For AAV-Based Gene Therapies

Kriya Therapeutics, based in Redwood City, Calif. and Research Triangle Park, NC, closed on a Series B financing worth $100 million.

July 14, 2021
·
2 min read
·
Mark Terry
Biotech Bay

Money on the Move: July 7 – 13

More biopharma companies race toward the Nasdaq this week, while a few rake in cash via private funding rounds.

July 14, 2021
·
4 min read
·
Kate Goodwin